How Chlorhexidine Sponges Prevent Bloodstream Infections

A chlorhexidine sponge is a small, flat pad saturated with chlorhexidine gluconate (CHG) that sits directly against the skin at a catheter insertion site, slowly releasing antiseptic to keep bacteria from colonizing the area and entering the bloodstream. These devices are a mainstay of infection prevention in intensive care units, where a meta-analysis of nine randomized trials found they cut catheter-related bloodstream infections by roughly 40 to 50 percent compared with standard dressings. The concept is straightforward, but the details around when they work best, who should avoid them, and what newer alternatives look like are worth understanding.

How Chlorhexidine Kills Bacteria at the Catheter Site

Chlorhexidine is a positively charged molecule, and bacterial cell surfaces carry a negative charge. That electrical mismatch is the first step: the chlorhexidine molecule is drawn toward the bacterium and binds tightly to its outer wall. Once attached, it slips through the cell wall by passive diffusion and damages the inner membrane, making it leaky. Low-molecular-weight molecules and ions spill out of the cell, and membrane-bound enzymes stop working properly. At lower concentrations, this effect is reversible; the bacterium is stunned but not dead. If the concentration stays elevated or rises, the damage becomes permanent: the cell’s internal contents coagulate and the organism dies.

Research on model lipid membranes has added a layer to this picture. Rather than simply poking holes in cell membranes, chlorhexidine appears to stiffen them, disrupting the flexible microdomains that transmembrane proteins need to function. The membrane does not spring a dramatic leak; it loses the mechanical properties bacteria rely on to survive.

What makes this mechanism useful in a sponge format is that chlorhexidine keeps working at low concentrations and acts against both aerobic and anaerobic bacteria, as well as fungi. A sponge sitting at a catheter site does not need to flood the area with antiseptic; a slow, sustained release is enough to maintain a zone of inhibition right where bacteria would otherwise travel along the catheter and into the bloodstream.

Evidence for Preventing Bloodstream Infections

The landmark trial that put chlorhexidine sponges on the map enrolled critically ill adults in French ICUs. Patients whose central venous or arterial catheters were dressed with a chlorhexidine-impregnated sponge had roughly 60 percent fewer major catheter-related infections than those with standard dressings, and about 75 percent fewer catheter-related bloodstream infections specifically. The sponge group saw bloodstream infections drop to 0.40 per 1,000 catheter-days, compared with 1.3 per 1,000 catheter-days in the control group. To put that in practical terms, using the sponge prevented one major infection for every 117 catheters dressed.

Those findings held up when researchers pooled results across studies. A meta-analysis combining nine randomized controlled trials found that chlorhexidine-impregnated dressings reduced catheter-related bloodstream infection risk by about 43 percent and catheter colonization by about half.

⁴

An economic analysis of the same large French trial confirmed that the sponge also saved money by preventing infections, even in ICUs where baseline infection rates were already low. Central line infections are expensive to treat, and the cost of adding a chlorhexidine sponge to a dressing is modest by comparison.

⁵

Sponge Versus Gel Dressings

The traditional chlorhexidine sponge is a foam-like pad placed under a transparent film dressing. In recent years, manufacturers have introduced gel-based dressings that incorporate chlorhexidine directly into the adhesive layer of a transparent film, eliminating the separate sponge. The question for hospitals is whether the newer design is better, worse, or equivalent.

A head-to-head comparison in French ICUs found that the gel dressing and the sponge dressing provided similar protection against major catheter-related infections and bloodstream infections. Where they diverged was in practical handling and side effects. Gel dressings had fewer dressing disruptions, meaning they stayed in place more reliably. However, they were associated with significantly more contact dermatitis, roughly 3.6 times the rate seen with sponge dressings.

⁶

A separate large study comparing the two formats found a 41 percent lower bloodstream infection rate with the gel dressing than with the sponge. That result sounds decisive, but it is worth noting that this was a comparative cohort study rather than a randomized trial, and differences in patient populations or clinical practices could partly explain the gap.

⁷

In practice, most hospitals choose between the two formats based on a mix of infection rates, skin tolerance, and how often nurses have to change disrupted dressings. Neither format is clearly superior for every patient. If a patient’s skin reacts to the gel, switching to the sponge makes sense, and vice versa.

Skin Reactions and How to Spot Them

Contact dermatitis is the most common adverse effect of chlorhexidine sponges. In the large French trial mentioned earlier, severe contact dermatitis occurred in about 5.3 per 1,000 catheters dressed with the sponge. That sounds rare, and it is, but in an ICU with hundreds of catheter placements each year, nursing staff will encounter it.

⁸

The reaction can be more dramatic than ordinary redness. A case series described seven patients, six of them infants and toddlers, who developed erosive irritant contact dermatitis under chlorhexidine-containing dressings. The skin broke down with open erosions that initially looked like they might be infected, prompting extensive workups that came back negative. The lesions cleared once the chlorhexidine dressings were removed and replaced with alternative antimicrobial dressings.

⁹

Several patterns stood out in those cases. Femoral catheter sites were involved in all but one patient, likely because the groin area stays warmer and more occluded. Four of the seven were immunosuppressed after organ transplants, and all were receiving blood pressure support at the time. Critically ill patients with compromised blood flow to the skin seem to be at higher risk. The takeaway for bedside nurses is that any new erosion or reddening around a catheter site dressed with a chlorhexidine sponge warrants removing the dressing and inspecting the skin rather than assuming infection.

Rare but Serious Allergic Reactions

Beyond local irritation, true allergic reactions to chlorhexidine exist. Anaphylaxis to chlorhexidine is rare, but it can be life-threatening.

¹⁰

As hospitals have expanded their use of chlorhexidine across multiple products, from surgical skin prep to oral rinses to catheter dressings, the number of reported allergic cases has increased. Reports include anaphylaxis linked to gels used on mucous membranes, chlorhexidine-impregnated catheters, wound preparations, and dental procedures. Several governments have issued warnings about the allergy risk when chlorhexidine contacts mucosal surfaces or is used in implanted or indwelling devices.

¹¹

The tricky part is that chlorhexidine is in so many products that a patient may not realize what triggered the reaction. If someone has an unexplained anaphylactic episode during or after a procedure, chlorhexidine should be on the short list of suspects, especially when the patient has a catheter site dressed with a CHG sponge or has been washed with a CHG-based skin prep. Allergy testing for chlorhexidine is available but is not yet routine in most preoperative assessments.

Using Chlorhexidine Sponges in Children and Neonates

Pediatric use has been a source of caution. Neonatal skin is thinner and more permeable, raising concerns about both local injury and systemic absorption. Still, there is evidence that chlorhexidine sponges can be used safely in this population. A randomized study in infants and children after cardiac surgery found that the sponge significantly reduced catheter colonization. Local redness was noted in four patients in the sponge group compared to one in the control group, a mild finding overall, and the investigators concluded the device was safe.

¹²

A more recent study looked at chlorhexidine-based surgical site preparation in neonatal ICU surgical patients and reported no adverse effects in the chlorhexidine group.

¹³

That said, the case series of erosive dermatitis described earlier included children as young as four months. Very young, critically ill, or immunosuppressed infants deserve extra vigilance. Many pediatric ICUs now use chlorhexidine sponges selectively, monitoring the insertion site more frequently in neonates than they would in adults and switching to a non-CHG dressing at the first sign of skin breakdown.

Does Chlorhexidine Breed Resistant Bacteria?

Whenever an antiseptic is used extensively, the question of resistance surfaces. In the large French trial, the investigators specifically checked for this and found that using sponge dressings was not associated with greater bacterial resistance in skin samples taken at catheter removal.

¹⁴

Laboratory research, however, tells a more cautious story. When Klebsiella pneumoniae isolates were exposed to chlorhexidine in a controlled setting, some developed mutations in regulatory genes that ramped up the activity of efflux pumps, essentially molecular bouncers that shove the antiseptic back out of the cell before it can do damage. These same mutations also conferred cross-resistance to colistin, a last-resort antibiotic used for multidrug-resistant infections.

¹⁵

The gap between lab and bedside matters here. In the real world, chlorhexidine sponges are used at a single catheter site for days to weeks, not slathered across entire body surfaces for months. The drug concentrations right at the sponge tend to remain high enough to kill bacteria outright rather than merely stun them, which is the scenario most likely to select for resistance. The lab findings are a reason to monitor, not a reason to stop using the devices, but they are also a reminder that chlorhexidine products should not be used indiscriminately where they are not needed.

What Happens to Your Skin Microbiome

Beyond the target pathogens, a chlorhexidine sponge sits on a patch of skin teeming with commensal bacteria that play their own protective roles. A pilot study that tracked the skin microbiome for 72 hours after chlorhexidine treatment found that the overall microbial community was not dramatically different from untreated skin at 24, 48, or 72 hours. A handful of species became more abundant after treatment, but the community as a whole rebounded quickly.

¹⁶

A separate study using viability-based methods, which distinguish living bacteria from dead ones, found a more nuanced picture. On the day of surgery, sites that had been prepped with chlorhexidine showed a spike in the relative abundance of several genera associated with surgical site infections, including Acinetobacter, Bacillus, and Pseudomonas. Some Bacillus species isolated from subjects showed high intrinsic resistance to chlorhexidine. The good news is that these microbiome shifts were largely transient, returning toward baseline over time.

¹⁷

The practical implication is counterintuitive. Chlorhexidine kills a broad swath of skin bacteria, but the survivors and early recolonizers are not a random mix; they skew toward organisms that are naturally tougher, some of which are potential pathogens. Over days, the normal flora recovers and these tougher organisms get crowded back out. For a chlorhexidine sponge sitting on a catheter site for an extended period, this means the continuous low-level release of antiseptic is doing meaningful work, because the window right after initial application is when the microbial neighborhood is most unbalanced.

The Cost-Effectiveness Case

A cost-effectiveness analysis modeled a 30-day ICU scenario and found that chlorhexidine dressings were almost the same price per patient as standard dressings, roughly €16,461 versus €16,320. The key difference appeared when infections occurred: treating a patient with a catheter-related bloodstream infection cost around €40,000, dwarfing the incremental cost of the dressing itself. The incremental cost per infection prevented was about €12,000, well below the cost of caring for an infected patient. A probabilistic analysis found the chlorhexidine dressing to be the more effective strategy in 99.7 percent of simulations.

¹⁸

This economic argument has been one of the main drivers of adoption. Even hospitals that balk at the per-unit cost of chlorhexidine sponges compared with plain transparent dressings tend to come around once they see the avoided costs of treating bloodstream infections, which include extended ICU stays, additional antibiotics, and sometimes legal exposure.

Chlorhexidine in the Water Supply

An angle that rarely comes up in hospital infection-control meetings is what happens to all this chlorhexidine after it leaves the patient. A study analyzing sewage sludge from municipal wastewater treatment plants in northwest Spain found that chlorhexidine was present in every sample tested, at concentrations ranging from 0.3 to 16 micrograms per gram of sludge. The researchers tested those concentrations against common microorganisms and found that even the lowest sludge levels were three times higher than the threshold that killed Candida albicans in lab assays. Escherichia coli and Staphylococcus aureus were also affected at somewhat higher concentrations.

¹⁹

On the plant side, the news was more reassuring. At the concentrations found in sludge, chlorhexidine did not affect the germination of test seeds, suggesting that spreading sludge on agricultural land would not harm crops. But the potential disruption to microbial communities in wastewater treatment plants, which depend on healthy bacterial populations to break down waste, is an open question. Hospital and municipal planners increasingly think about the environmental footprint of antiseptics, and chlorhexidine is one of the compounds on their watch list. As use expands, so does the volume flowing into waterways, and the same broad-spectrum killing power that makes chlorhexidine valuable at the bedside makes it a concern downstream.